Special Session 20

3月27日[土]09:45-11:15

 
  Future potential as a drug of natriuretic peptides
 
 
   
  ナトリウム利尿ペプチド関連薬剤としてはカルペリチドとARNIがあるが、さらに新しい薬剤も考案されている。この分野の発展は心不全治療の向上と病態生理の解明に繋がると期待されており、議論を深めたい。
 
 
   
 
 
Michihiro Yoshimura   Michihiro Yoshimura
Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo
  John C Burnett Jr   John C Burnett Jr
Cardiovascular Medicine Mayo Clinic, Mayo Clinic, Rochester, USA
 
 
   
 
 
John C Burnett Jr   John C Burnett Jr
Cardiovascular Medicine Mayo Clinic, Mayo Clinic, Rochester, USA
  Elijah Bolotin   Elijah Bolotin
PharmaIN Corporation CEO, PharmaIN Corporation, Bothell, USA
 
 
 
Hitoshi Nakagawa   Hitoshi Nakagawa
Department of Cardiovascular Medicine, Nara Medical University, Kashihara
  Yasuaki Nakagawa   Yasuaki Nakagawa
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto
 
 
 
Tomohisa Nagoshi   Tomohisa Nagoshi
Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo